Roscetti G, Ambrosio C, Trabucchi M, Massotti M, Barbaccia M L
Dip. to Medicina Sperimentale, Università di Roma, Tor Vergata, Italy.
Eur J Pharmacol. 1994 Sep 15;269(1):17-24. doi: 10.1016/0922-4106(94)90021-3.
The modulation of cyclic AMP dependent neurosteroidogenesis was studied in minces prepared from the cerebral cortex of adult rat. Forskolin or dibutyryl-cyclic AMP enhanced pregnenolone and progesterone production in a time and dose-dependent manner. The forskolin effect was mimicked by the cyclic AMP phosphodiesterase inhibitor isobutyl-methyl-xanthine, but not by the adenylate cyclase inactive forskolin analogue 1,9,dideoxy-forskolin. 4'-Chloro-diazepam, a high affinity ligand for the mitochondrial diazepam binding inhibitor (DBI) receptor, also elicited a time dependent increase in steroidogenesis. The forskolin and the 4'-chloro-diazepam stimulated pregnenolone increase was prevented by preexposing the rat brain cortical minces to 1-(2-chlorophenyl)-N-methyl-N-(1-methyl-propyl)-3-isoquinoline carboxamide (PK 11195), a high affinity ligand for the mitochondrial DBI receptor endowed with antagonistic properties. The protein synthesis inhibitor cycloheximide prevented the forskolin and 4'-chloro-diazepam stimulation of pregnenolone formation. In brain cortical minces of adrenalectomised/orchiectomised rats dibutyryl-cyclic AMP increased both pregnenolone and progesterone formation, while forskolin only increased progesterone. These data show that cyclic AMP enhances brain steroidogenesis by acting on a labile protein substrate which interacts with the mitochondrial DBI receptor.
在成年大鼠大脑皮质制备的组织匀浆中研究了环磷酸腺苷(cAMP)依赖性神经甾体生成的调节。福斯可林或二丁酰环磷腺苷以时间和剂量依赖性方式增强孕烯醇酮和孕酮的生成。环磷酸腺苷磷酸二酯酶抑制剂异丁基甲基黄嘌呤可模拟福斯可林的作用,但腺苷酸环化酶无活性的福斯可林类似物1,9 - 二脱氧福斯可林则不能。4'-氯地西泮是线粒体地西泮结合抑制剂(DBI)受体的高亲和力配体,也能引起甾体生成的时间依赖性增加。预先将大鼠脑皮质组织匀浆暴露于1 - (2 - 氯苯基)-N - 甲基 - N - (1 - 甲基丙基)-3 - 异喹啉甲酰胺(PK 11195),一种具有拮抗特性的线粒体DBI受体高亲和力配体,可阻止福斯可林和4'-氯地西泮刺激孕烯醇酮增加。蛋白质合成抑制剂环己酰亚胺可阻止福斯可林和4'-氯地西泮对孕烯醇酮形成的刺激作用。在肾上腺切除/去势大鼠的脑皮质组织匀浆中,二丁酰环磷腺苷增加了孕烯醇酮和孕酮的形成,而福斯可林仅增加了孕酮。这些数据表明,环磷酸腺苷通过作用于与线粒体DBI受体相互作用的不稳定蛋白质底物来增强脑甾体生成。